Overview

Acetazolamide for the Prevention of High Altitude Illness: a Comparison of Dosing

Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
This is a phase 4, randomized, double-blinded interventional trial comparing alternative doses of Acetazolamide for the prevention of High Altitude Illness.
Phase:
Phase 4
Details
Lead Sponsor:
University of Utah
Treatments:
Acetazolamide